Syndax Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Syndax Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Syndax Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Syndax Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $894k | 41k | 21.86 |
| 2022-12-31 | $268k | 11k | 25.45 |
| 2022-09-30 | $861k | 36k | 24.04 |
| 2021-09-30 | $220k | 12k | 19.08 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management